ArticleFrontiers in neurology2022

Accelerate Clinical Trials in Charcot-Marie-Tooth Disease (ACT-CMT): A Protocol to Address Clinical Trial Readiness in CMT1A.

Katy Eichinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.